IBDEI271 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,35030,1,4,0)
;;=4^G81.92
;;^UTILITY(U,$J,358.3,35030,2)
;;=^5004122
;;^UTILITY(U,$J,358.3,35031,0)
;;=G81.94^^137^1792^7
;;^UTILITY(U,$J,358.3,35031,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,35031,1,3,0)
;;=3^Hemiplegia,Unspec Affecting Left Nondominant Side
;;^UTILITY(U,$J,358.3,35031,1,4,0)
;;=4^G81.94
;;^UTILITY(U,$J,358.3,35031,2)
;;=^5004124
;;^UTILITY(U,$J,358.3,35032,0)
;;=G81.91^^137^1792^8
;;^UTILITY(U,$J,358.3,35032,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,35032,1,3,0)
;;=3^Hemiplegia,Unspec Affecting Right Dominant Side
;;^UTILITY(U,$J,358.3,35032,1,4,0)
;;=4^G81.91
;;^UTILITY(U,$J,358.3,35032,2)
;;=^5004121
;;^UTILITY(U,$J,358.3,35033,0)
;;=G81.93^^137^1792^9
;;^UTILITY(U,$J,358.3,35033,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,35033,1,3,0)
;;=3^Hemiplegia,Unspec Affecting Right Nondominant Side
;;^UTILITY(U,$J,358.3,35033,1,4,0)
;;=4^G81.93
;;^UTILITY(U,$J,358.3,35033,2)
;;=^5004123
;;^UTILITY(U,$J,358.3,35034,0)
;;=I69.942^^137^1792^22
;;^UTILITY(U,$J,358.3,35034,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,35034,1,3,0)
;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Dominant Side
;;^UTILITY(U,$J,358.3,35034,1,4,0)
;;=4^I69.942
;;^UTILITY(U,$J,358.3,35034,2)
;;=^5133582
;;^UTILITY(U,$J,358.3,35035,0)
;;=I69.944^^137^1792^23
;;^UTILITY(U,$J,358.3,35035,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,35035,1,3,0)
;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Nondominant Side
;;^UTILITY(U,$J,358.3,35035,1,4,0)
;;=4^I69.944
;;^UTILITY(U,$J,358.3,35035,2)
;;=^5133585
;;^UTILITY(U,$J,358.3,35036,0)
;;=I69.941^^137^1792^24
;;^UTILITY(U,$J,358.3,35036,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,35036,1,3,0)
;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Dominant Side
;;^UTILITY(U,$J,358.3,35036,1,4,0)
;;=4^I69.941
;;^UTILITY(U,$J,358.3,35036,2)
;;=^5133581
;;^UTILITY(U,$J,358.3,35037,0)
;;=I69.943^^137^1792^25
;;^UTILITY(U,$J,358.3,35037,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,35037,1,3,0)
;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Nondominant Side
;;^UTILITY(U,$J,358.3,35037,1,4,0)
;;=4^I69.943
;;^UTILITY(U,$J,358.3,35037,2)
;;=^5133584
;;^UTILITY(U,$J,358.3,35038,0)
;;=G35.^^137^1792^26
;;^UTILITY(U,$J,358.3,35038,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,35038,1,3,0)
;;=3^Multiple sclerosis
;;^UTILITY(U,$J,358.3,35038,1,4,0)
;;=4^G35.
;;^UTILITY(U,$J,358.3,35038,2)
;;=^79761
;;^UTILITY(U,$J,358.3,35039,0)
;;=G20.^^137^1792^27
;;^UTILITY(U,$J,358.3,35039,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,35039,1,3,0)
;;=3^Parkinson's disease
;;^UTILITY(U,$J,358.3,35039,1,4,0)
;;=4^G20.
;;^UTILITY(U,$J,358.3,35039,2)
;;=^5003770
;;^UTILITY(U,$J,358.3,35040,0)
;;=R56.9^^137^1792^3
;;^UTILITY(U,$J,358.3,35040,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,35040,1,3,0)
;;=3^Convulsions,Unspec
;;^UTILITY(U,$J,358.3,35040,1,4,0)
;;=4^R56.9
;;^UTILITY(U,$J,358.3,35040,2)
;;=^5019524
;;^UTILITY(U,$J,358.3,35041,0)
;;=S06.9X5S^^137^1792^14
;;^UTILITY(U,$J,358.3,35041,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,35041,1,3,0)
;;=3^Intcrn injury w LOC >24 hr w ret consc lev, sequela
;;^UTILITY(U,$J,358.3,35041,1,4,0)
;;=4^S06.9X5S
;;^UTILITY(U,$J,358.3,35041,2)
;;=^5021223
;;^UTILITY(U,$J,358.3,35042,0)
;;=S06.9X6S^^137^1792^15
;;^UTILITY(U,$J,358.3,35042,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,35042,1,3,0)
;;=3^Intcrn injury w LOC >24 hr w/o ret consc w surv, sqla
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI271 3835 printed Apr 09, 2024@21:36:05 Page 2
IBDEI271 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,35030,1,4,0)
+2 ;;=4^G81.92
+3 ;;^UTILITY(U,$J,358.3,35030,2)
+4 ;;=^5004122
+5 ;;^UTILITY(U,$J,358.3,35031,0)
+6 ;;=G81.94^^137^1792^7
+7 ;;^UTILITY(U,$J,358.3,35031,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,35031,1,3,0)
+10 ;;=3^Hemiplegia,Unspec Affecting Left Nondominant Side
+11 ;;^UTILITY(U,$J,358.3,35031,1,4,0)
+12 ;;=4^G81.94
+13 ;;^UTILITY(U,$J,358.3,35031,2)
+14 ;;=^5004124
+15 ;;^UTILITY(U,$J,358.3,35032,0)
+16 ;;=G81.91^^137^1792^8
+17 ;;^UTILITY(U,$J,358.3,35032,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,35032,1,3,0)
+20 ;;=3^Hemiplegia,Unspec Affecting Right Dominant Side
+21 ;;^UTILITY(U,$J,358.3,35032,1,4,0)
+22 ;;=4^G81.91
+23 ;;^UTILITY(U,$J,358.3,35032,2)
+24 ;;=^5004121
+25 ;;^UTILITY(U,$J,358.3,35033,0)
+26 ;;=G81.93^^137^1792^9
+27 ;;^UTILITY(U,$J,358.3,35033,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,35033,1,3,0)
+30 ;;=3^Hemiplegia,Unspec Affecting Right Nondominant Side
+31 ;;^UTILITY(U,$J,358.3,35033,1,4,0)
+32 ;;=4^G81.93
+33 ;;^UTILITY(U,$J,358.3,35033,2)
+34 ;;=^5004123
+35 ;;^UTILITY(U,$J,358.3,35034,0)
+36 ;;=I69.942^^137^1792^22
+37 ;;^UTILITY(U,$J,358.3,35034,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,35034,1,3,0)
+40 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Dominant Side
+41 ;;^UTILITY(U,$J,358.3,35034,1,4,0)
+42 ;;=4^I69.942
+43 ;;^UTILITY(U,$J,358.3,35034,2)
+44 ;;=^5133582
+45 ;;^UTILITY(U,$J,358.3,35035,0)
+46 ;;=I69.944^^137^1792^23
+47 ;;^UTILITY(U,$J,358.3,35035,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,35035,1,3,0)
+50 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Nondominant Side
+51 ;;^UTILITY(U,$J,358.3,35035,1,4,0)
+52 ;;=4^I69.944
+53 ;;^UTILITY(U,$J,358.3,35035,2)
+54 ;;=^5133585
+55 ;;^UTILITY(U,$J,358.3,35036,0)
+56 ;;=I69.941^^137^1792^24
+57 ;;^UTILITY(U,$J,358.3,35036,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,35036,1,3,0)
+60 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Dominant Side
+61 ;;^UTILITY(U,$J,358.3,35036,1,4,0)
+62 ;;=4^I69.941
+63 ;;^UTILITY(U,$J,358.3,35036,2)
+64 ;;=^5133581
+65 ;;^UTILITY(U,$J,358.3,35037,0)
+66 ;;=I69.943^^137^1792^25
+67 ;;^UTILITY(U,$J,358.3,35037,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,35037,1,3,0)
+70 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Nondominant Side
+71 ;;^UTILITY(U,$J,358.3,35037,1,4,0)
+72 ;;=4^I69.943
+73 ;;^UTILITY(U,$J,358.3,35037,2)
+74 ;;=^5133584
+75 ;;^UTILITY(U,$J,358.3,35038,0)
+76 ;;=G35.^^137^1792^26
+77 ;;^UTILITY(U,$J,358.3,35038,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,35038,1,3,0)
+80 ;;=3^Multiple sclerosis
+81 ;;^UTILITY(U,$J,358.3,35038,1,4,0)
+82 ;;=4^G35.
+83 ;;^UTILITY(U,$J,358.3,35038,2)
+84 ;;=^79761
+85 ;;^UTILITY(U,$J,358.3,35039,0)
+86 ;;=G20.^^137^1792^27
+87 ;;^UTILITY(U,$J,358.3,35039,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,35039,1,3,0)
+90 ;;=3^Parkinson's disease
+91 ;;^UTILITY(U,$J,358.3,35039,1,4,0)
+92 ;;=4^G20.
+93 ;;^UTILITY(U,$J,358.3,35039,2)
+94 ;;=^5003770
+95 ;;^UTILITY(U,$J,358.3,35040,0)
+96 ;;=R56.9^^137^1792^3
+97 ;;^UTILITY(U,$J,358.3,35040,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,35040,1,3,0)
+100 ;;=3^Convulsions,Unspec
+101 ;;^UTILITY(U,$J,358.3,35040,1,4,0)
+102 ;;=4^R56.9
+103 ;;^UTILITY(U,$J,358.3,35040,2)
+104 ;;=^5019524
+105 ;;^UTILITY(U,$J,358.3,35041,0)
+106 ;;=S06.9X5S^^137^1792^14
+107 ;;^UTILITY(U,$J,358.3,35041,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,35041,1,3,0)
+110 ;;=3^Intcrn injury w LOC >24 hr w ret consc lev, sequela
+111 ;;^UTILITY(U,$J,358.3,35041,1,4,0)
+112 ;;=4^S06.9X5S
+113 ;;^UTILITY(U,$J,358.3,35041,2)
+114 ;;=^5021223
+115 ;;^UTILITY(U,$J,358.3,35042,0)
+116 ;;=S06.9X6S^^137^1792^15
+117 ;;^UTILITY(U,$J,358.3,35042,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,35042,1,3,0)
+120 ;;=3^Intcrn injury w LOC >24 hr w/o ret consc w surv, sqla
